Rabies

exp date isn't null, but text field is

Introduction

  • An acute progressive encephalitis zoonotic disease caused by a bullet-shaped rhabdovirus called rabies virus
  • The virus is a single-stranded enveloped RNA virus and has the potential to infect all mammals
  • Transmitted by infected secretions, usually saliva
  • Infected dogs are responsible for 99% of human rabies infection
  • Wildlife -foxes, wolves, jackals, bats, racoons, skunks, or mongoose account for a small proportion of transmission in non-endemic countries
  • Infection occurs from scratch and bites or when infected secretions are in direct contact with exposed skin or mucous membranes
  • Occasionally contact with a virus-containing aerosol or the ingestion or transplant of infected tissues may initiate the disease process

Clinical features

After an incubation period of 1 to 3 months (sometimes from 1 week to 1 year), infected patients develop:

  • Symptoms around site of bite/scratch
    • Pain
    • Parasthesiae
  • A non-specific prodrome of 1 - 4 days consisting of
    • Fever
    • Headache
    • Malaise
    • Myalgia
    • Anorexia
    • Nausea
    • Vomiting
    • Sore throat
    • Cough
    • Paraesthesia
  •  An acute encephalitic stage (presenting as forms of furious or paralytic rabies)
    • Furious rabies
    • Signs of hyperactivity-agitation, combativeness, restlessness
    • Excitable behaviour
    • Hallucinations and pyschosis
    • Confusion
    • Muscle spasms
    • Meningismus
    • Seizures
    • Hydrophobia (fear of water)
    • Sometimes aerophobia (fear of drafts or of fresh air).
    • Death occurs after a few days due to cardio-respiratory
    • Paralytic
    • Muscles gradually become paralyzed, starting at the site of the bite or
    • A coma slowly develops, and eventually death
    • Brainstem dysfunction
    • Diplopia
    • Facial paralysis
    • Optic neuritis
    • Difficulty with deglutition
    • Priapism
    • Spontaneous ejaculation
    • Coma

Rabies, once symptomatic is usually fatal

Differential diagnoses

  • Gullain-Barre syndrome
  • Other causes of viral encephalitis
  • Poliomyelitis
  • Allergic encephalomyelitis

Diagnoses

  • By diagnostic techniques detecting whole viruses, viral antigens, or nucleic acids in infected tissues (brain, skin, or saliva) intra-vitam and postmortem
  • Fluorescent antibody testing on brain tissue is the gold standard for rabies diagnosis

Investigations

  • Full Blood Count and differentials
  • Urea and Electrolytes
  • Culture of secretions
  • Cerebro Spinal Fluid (C SF) analysis
  • Serology
  • Pulmonary Chain Reaction (PCR)
  • Direct rapid immunohistochemistry tests
  • Enzyme-linked immunosorbent assays

Treatment goals

  • Disinfect wound; avoid early suturing
  • Provide passive immunization with antirabies antiserum
  • Provide active immunization with the vaccine

Non-drug treatment

Wound care

The wound or site of exposure should be:

  • Cleansed under running water
  • Washed for several minutes with soapy water
  • Disinfected and dressed simply

It should not be sutured immediately

Drug treatment

Purified cell culture and embryonated egg-based rabies vaccines (CCEEVs) is recommended.

  • CCEEVs can be administered by intradermal (ID) or IM injection
  • Post-exposure prophylaxis (PEP) and Pre-exposure (PrEP) regimens require a series of vaccine injections according to the manufacturers recommended schedules
  • Most vaccine manufacturers currently recommend:
    • for PrEP a 1-site IM 3-dose regimen and
    • for PEP a 1-site IM 5-dose regimen on days 0, 3, 7, 14 and 28 or
    • 4-dose Zagreb regimen (2-site IM on day 0 and 1-site IM on days 7 and 21).

Schedules

  • Unimmunized persons or those whose prophylaxis is probably incomplete.
  • Rabies (purified cell culture) vaccine:
    • Adult: 1 ml by deep subcutaneous or intramuscular injection in the deltoid region on days 0, 3, 7, 14 and 28

Plus:

  • Rabies immunoglobulin (RIG) given on day 0
    • Maximum dose calculation for RIG is 40 IU/kg body weight for equine derived RIG (eRIG), and 20 IU/kg body weight for human derived RIG (hRIG).
    • Child: same as for Adult
  • For fully immunized persons:
  • Rabies (purified cell culture) vaccine
    • Adult: 1 ml by deep subcutaneous or intramuscular injection in the deltoid region on days 1 and 3
    • Child: same as for adult

Post-exposure prophylaxis (PEP)

  • Should be initiated as soon as possible after exposure
  • The decision to initiate PEP should be based on contact categories below:

Categories of contact with suspect rabid animal

Description

PEP

Category I

Touching or feeding animals, animal licks on intact skin (no exposure)

Washing of exposed skin surfaces, no PEP

Category II

Nibbling of uncovered skin, minor scratches, or abrasions without bleeding (exposure)

Wound and immediate vaccination

Category III

Single or multiple transdermal bites or scratches, contamination of mucous membrane or broken skin with saliva from animal licks, exposures due to direct contact with bats (severe exposure)

Wound washing, immediate vaccination, and administration of rabies immunoglobulin

 

  • Pregnancy not a contraindication to rabies vaccine

Supportive measures

  • Allay anxiety: reassure
  • Other measures as appropriate for clinical situation

Prevention

Pre-exposure prophylaxis

Should be offered to persons at high risk of exposure and/or contact with rabies virus:

  • Veterinarians
  • Cave explorers
  • Laboratory workers who handle the rabies virus
  • Animal handlers
  • Workers in quarantine stations
  • Field workers who are likely to be bitten by infected wild animals
  • Certain port officials Bat handlers
  • Persons living in (or traveling to) areas where rabies is enzootic and/or where there is limited access to prompt medical care.
  • Those caring for patients caring for patients with rabies (Although there is no proven evidence of human transmission)
  • If there is substantial risk of exposure, and rapid access to post-exposure prophylaxis is limited, give pre-exposure prophylaxis Rabies vaccine

PrEP schedule

  • 2-site ID vaccine administered on days 0 and 7

Or

  • 1-site IM vaccine administration on days 0 and (1 ml by deep subcutaneous or intramuscular injection in the deltoid region)

Booster doses every 2 - 3 years for those at continued risk